Andrew Karter to Cholesterol, LDL
This is a "connection" page, showing publications Andrew Karter has written about Cholesterol, LDL.
Connection Strength
0.832
-
Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl. Am J Cardiol. 2015 Dec 01; 116(11):1700-4.
Score: 0.494
-
The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users. J Gen Intern Med. 2011 Dec; 26(12):1396-402.
Score: 0.093
-
Adherence to laboratory test requests by patients with diabetes: the Diabetes Study of Northern California (DISTANCE). Am J Manag Care. 2011 May; 17(5):339-44.
Score: 0.091
-
High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004 Feb; 10(2 Pt 2):163-70.
Score: 0.055
-
Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb; 31(2):188-195.
Score: 0.032
-
Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care. 2015 May; 38(5):905-12.
Score: 0.030
-
Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study. Med Care. 2009 Jun; 47(6):700-6.
Score: 0.020
-
Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research into Action for Diabetes (TRIAD). Med Care. 2007 Dec; 45(12):1144-53.
Score: 0.018